{"nctId":"NCT02174419","briefTitle":"Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis","startDateStruct":{"date":"2015-03"},"conditions":["Prurigo Nodularis","Nodularis Prurigo","Prurigo","Pruritus"],"count":62,"armGroups":[{"label":"nalbuphine HCl ER 90mg","type":"EXPERIMENTAL","interventionNames":["Drug: nalbuphine HCl ER tablets 90 mg BID"]},{"label":"nalbuphine HCl ER 180 mg","type":"EXPERIMENTAL","interventionNames":["Drug: nalbuphine HCl ER tablets 180 mg BID"]},{"label":"Sugar pill","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo tablets BID"]}],"interventions":[{"name":"nalbuphine HCl ER tablets 90 mg BID","otherNames":["nalbuphine ER"]},{"name":"nalbuphine HCl ER tablets 180 mg BID","otherNames":["nalbuphine ER"]},{"name":"Placebo tablets BID","otherNames":["sugar pill"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subject suffering from generalized prurigo nodularis\n* Have demonstrated pruritus intensity during screening\n* Male or female who are at least 18 years old at the time of consent\n\nExclusion Criteria:\n\n* Subject has chronic pruritus resulting from other conditions\n* Subject has a history of substance abuse within the past year\n* Subject has a known drug allergy to opioids\n* Subject is a pregnant or lactating female","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline to the Evaluation Visit (Week 10) in Itch on the 0-10 Numerical Rating Scale","description":"The number of subjects who reported at least a 30% reduction from baseline to Week 10, expressed as a percentage of subjects in the particular arm/group who were evaluated,","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27.3","spread":null},{"groupId":"OG001","value":"44.4","spread":null},{"groupId":"OG002","value":"36.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to the Evaluation Visit (Week 10) in the Mean Itch on the 0-10 Numerical Rating Scale","description":null,"classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Change From Baseline to the Evaluation Visit (Week 10) in the Verbal Rating Scale","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":22},"commonTop":[]}}}